Chromosome sensitivity to bleomycin in G2 lymphocytes from Down syndrome patients

Brazilian Journal of Genetics

Volumn 20, Issue 1, 1997, Pages 79-85

  Bartholomei Santos, Marlise Ladvocat ^a   De Lucca, Edmundo José ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; BLEOMYCIN SULFATE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BLOOD CULTURE; CELL CYCLE G2 PHASE; CHILD; CHROMATID; CHROMOSOME ABERRATION; CONTROLLED STUDY; DNA STRAND BREAKAGE; DOWN SYNDROME; FEMALE; HUMAN; HUMAN CELL; INFANT; IONIZING RADIATION; LYMPHOCYTE CULTURE; MALE; TRISOMY 21;

EID: 0030914601     PISSN: 01008455     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0100-84551997000100015     Document Type: Article

References (27)

1. Bartholomei-Santos, M.L. and Lucca, E.J. (1995). Genetic susceptibility to bleomycin: a twin study. Rev. Ciênc. Bioméd. 16: 47-53.
2. Campos, H. (1983). Estatística Experimental Não-Paramétrica. ESALQ, Piracicaba, pp. 349.
3. Cherry, L.M. and Hsu, T.C. (1983). Bleomycin-induced chromosome damage in lymphocytes of medullary thyroid carcinoma patients and their family members. Anticancer Res. 3: 367-372.
4. Countryman, P.I., Heddle, J.A. and Crawford, E. (1977). The repair of X-ray-induced chromosomal damage in trisomy 21 and normal diploid lymphocytes. Cancer Res. 37: 52-58.
5. Dekaban, A.S., Thron, R. and Steusing, J.K. (1966). Chromosomal aberrations in irradiated blood and blood cultures of normal subjects and of selected patients with chromosomal abnormality. Radiat. Res. 27: 50-63.
6. Fong, C. and Brodeur, G.M. (1987). Down's syndrome and leukemia: epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis. Cancer Genet. Cytogenet. 28: 55-76.
7. Gattás, R.R. (1978). Elementos de Probabilidade e Inferência. Atlas São Paulo, São Paulo, pp. 267.
8. Hopwood, V., Hsu, T.C., Pathak, S., Ramkissoon, D., Newell, G.R. and Martin, J.D. (1989). Cytogenetic characteristics in a family: fragile 16q22, giant satellite, aneuploidy, and bleomycin sensitivity of three generations. Rev. Bras. Genet. 12: 379-390.
9. Hsu, T.C. (1987). Genetic predisposition to cancer with special reference to mutagen sensitivity. In Vitro 23: 591-603.
10. Hsu, T.C., Cherry, L.M. and Samaan, N.A. (1985). Differential mutagen susceptibility in cultured lymphocytes of normal individuals and cancer patients. Cancer Genet. Cytogenet. 17: 307-313.
11. Hsu, T.C., Johnston, D.A., Cherry, L.M., Ramkissoon, D., Schantz, S.P., Jessup, J.M., Winn, R.J., Shirley, L. and Furlong, C. (1989). Sensitivity to genotoxic effects of bleomycin in humans: possible relationship to environmental carcinogenesis. Int. J. Cancer 43: 403-409.
12. Ijima, K., Morimoto, K., Koizumi, A., Higurashi, M. and Hirayama, M. (1984). Bleomycin-induced chromosomal aberrations and sister chromatid exchanges in Down lymphocyte cultures. Hum. Genet. 66: 57-61.
13. Lambert, B., Hansson, K., Bui, T.H., Funes-Cravioto, F., Lindstein, J., Holmberg, M. and Strausmanis, R. (1976). DNA repair and frequency of X-ray and U.V.-light induced chromosome aberrations in leukocytes from patients with Down's syndrome. Ann. Hum. Genet. 39: 293-303.
14. Leonard, J.C. and Merz, T. (1983). The influence of cell cycle kinetics on the radiosensitivity of Down syndrome lymphocytes. Mutat. Res. 109: 111-121.
15. Leonard, J.C. and Merz, T. (1987). Chromosomal aberrations in irradiated Down's syndrome fibroblasts. Mutat. Res. 180: 223-230.
16. Morimoto, K., Kaneko, T., Iijima, K. and Koizumi, A. (1984). Proliferative kinetics and chromosome damage in trisomy 21 lymphocyte cultures exposed to γ-rays and bleomycin. Cancer Res. 44: 1499-1504.
17. Paris Conference (1972). Standardization in human cytogenetics. Chromosome measurements. Cytogenetics 11: 313-362.
18. Pelz, L., Götz, J., Krüger, G. and Witt, G. (1988). Increased methotrexate-induced chromosome breakage in patients with free trisomy 21 and their parents. Hum. Genet. 81: 38-40.
19. Preston, R.J. (1981). X-ray-induced chromosome aberrations in Down lymphocytes: an explanation of their increased sensitivity. Environ. Mutagen. 3: 85-89.
20. Sales, M.M. (1991). Suscetibilidade genética à bleomicina: estudo em famílias de pares de gêmeos suscetíveis. Monografia de Licenciatura em Ciências Biológicas, Instituto de Biociências, Universidade Estadual Paulista, Botucatu, SP.
21. Sandberg, A.A. (1986). The chromosomes in human leukemia. Semin. Hematol. 23: 201-217.
22. Shafik, H.M., Au, W.W. and Legator, M.S. (1988). Chromosomal radiosensitivity of Down syndrome lymphocytes at different stages of the cell cycle. Hum. Genet. 78: 71-75.
23. Shubber, E.K., Hamami, H.A., Allak, B.M.A. and Khaleel, A.H. (1991). Sister chromatid exchange in lymphocytes from infants with Down syndrome. Mutat. Res. 248: 61-72.
24. Vijayalaxmi, A. and Evans, H.J. (1982). Bleomycin-induced chromosomal aberrations in Down's syndrome lymphocytes. Mutat. Res. 105: 107-113.
25. Voreschovsky, I. and Juraskova, V. (1990). Bleomycin-induced chromosomal damage in tuberous sclerosis. Jpn. J. Hum. Genet. 35: 207-213.
26. Yanagisawa, S. (1978). Sister chromatid exchanges and the cell cycle in peripheral blood lymphocytes of Down syndrome. Proc. Japan Acad. 54 (ser. B): 173-178.
27. Zar, J.H. (1984). Bioestatistical Analysis. Prentice Hall International Editions, Englewood Cliffs, pp. 718.